One of the major risk factors for global death and disability is alcohol, tobacco, and illicit drug use. While there is increasing knowledge with respect to individual factors
promoting the initiation and maintenance of substance use disorders (SUDs), disease trajectories involved in losing and regaining control over drug intake (ReCoDe) are still not well described. Our newly formed German Collaborative Research Centre (CRC) on ReCoDe has an interdisciplinary approach funded by the German Research Foundation (DFG) with a 12-year perspective. The main goals of our research consortium are (i) to identify triggers and modifying factors that longitudinally modulate the trajectories of losing and regaining control over drug consumption in real life, (ii) to study underlying behavioral, cognitive, and neurobiological mechanisms, and (iii) to implicate mechanism-based interventions. These goals will be achieved by: (i) using mobile health (m-health) tools to longitudinally monitor the effects of triggers (drug cues, stressors, and priming doses) and modify factors (eg, age, gender, physical activity, and cognitive control) on drug consumption patterns in real-life conditions and in animal models of addiction; (ii) the identification and computational modeling of key mechanisms mediating the effects of such triggers and modifying factors on goaldirected, habitual, and compulsive aspects of behavior from human studies and animal models; and (iii) developing and testing interventions that specifically target the underlying mechanisms for regaining control over drug intake. We build a work plan and design the methodology to investigate the following core research domains:
1. Domain A: Defining individual trajectories of ReCoDe requires a holistic approach, which longitudinally assesses the interactions between triggers (drug cues, stressors, and priming doses) and modifying factors (eg, age, gender, physical activity, and cognitive functions) in real life in substance use disorder (SUD) subjects and in animal models of addiction. Technically, we will use mobile health (m-health) tools such as individual assessment devices fitted with mobile sensors (wearables) and accelerometers. The former technology will acquire geolocation and additional data on psychological and physiological cue and stress reactivity and on alcohol intake, while the latter will collect intensive longitudinal datasets (ILDs). These data will be combined with app-based tests for key cognitive control and learning mechanisms in real-life settings. We will analyze the data using new multiscale analysis tools from statistical physics and biosignal processing to identify tipping points in substance use trajectories. 3. Domain C: Based on the prediction of individual trajectories of losing and regaining control, we will develop mechanism-based interventions that specifically match the above-mentioned key processes (eg, cue reactivity, habitization, reduced choice of alternative rewards, and reduced cognitive control).
| RESEARCH DOMAIN A: DESCRIPTION OF ANTECEDENTS AND TRAJECTORIES OF LOSING AND REGAINING CONTROL AND MODULATING FACTORS
The first goal of this joint research effort is to identify triggers and modifying factors that longitudinally modulate the trajectories of losing and regaining control over drug consumption in real life across the lifespan.
Losing control over drug intake is a gradual and dimensional process, which starts with goal-directed drug intake and proceeds to habitual and ultimately compulsive drug use. Interestingly, a limited number of addicted subjects manage to regain behavioral control over compulsive drug intake without professional help, either by becoming abstinent (up to 19% of untreated alcohol-dependent patients) or by substantially reducing drug intake, for example, by decreasing tobacco or alcohol consumption. [1] [2] [3] [4] Even in patients with severe stages of alcohol dependence who require detoxification, a few percent manage to drink small amounts of alcohol for a longer period of time without again losing control. 5 Regaining behavioral control over drug intake has been attributed to mindful selection of goals replacing habitual behavior, extinction of drug cue-induced behavioral tendencies, regulation of drug craving and prioritization of alternative nondrug rewards, and increased cognitive control over behavior including inhibitory control. 3, [6] [7] [8] In Domain A of our CRC, we will identify common, as well as ageand gender-specific factors that contribute to losing and regaining control over consumption of alcohol (and other drugs of abuse), by a systematic longitudinal assessment of a large sample of persons with mild to moderate alcohol use disorder (AUD), who do not (yet) require detoxification. This traditional longitudinal cohort study approach F I G U R E 1 The losing and regaining control over drug intake (ReCoDe) framework to study losing and regaining control over drug intake over a 12-year perspective: Our 19 projects are divided into three research domains. Research domain A relates to trajectories of alcohol and drug intake. Research domain B relates to mechanisms (eg, cue reactivity) on different system levels (behavioral, neural, and molecular) and research domain C focusses on the modification of mechanisms (eg, by increasing cognitive control via physical activity or neurofeedback) using latent growth curve and growth mixture models 9 will be combined with in-depth ambulatory assessments several times a week.
We will use Ambulatory Assessment including Ecological Momentary Assessment (EMA) 10 to acquire ILDs over several months in AUD patients with and without additional tobacco and cannabis use. For EMA, we will use smartphones with additional mobile sensors (wearables) which will be used to measure physical activity, data on location (GPS), geolocation-based triggering of e-diaries, self-reported stress reactivity, cue exposure (encounter with drug-related stimuli in real life), drug craving, impulsivity, and drug consumption (priming doses, binges, and continuous use of all drugs of abuse). App-based brief questionnaires and cognitive 11 tasks that allow the assessment of momentary emotional, motivational, and cognitive states, including new brief games to assess Pavlovian and instrumental (model-based and model-free) learning mechanisms as well as sensors to detect physiological stress responses will be applied ( Figure 2) . The ILDs will undergo multiscale statistical analysis to identify early warning signs and critical phases 12 indicative for craving and drug use as reported online and as assessed in animal models of addiction. ILDs will also be collected to acquire predictive models of single subjects and their behavioral dynamics, using cutting-edge AI techniques like deep recurrent neural networks. 13 The influence of age and gender, as well as adverse life events on the occurrence of early warning signs and critical phases, will be studied in humans and in related animal experiments. DSM-IV/5-based animal models of addictive-like behavior 14, 15 will be run in parallel for sampling ILDs and for running modulating factors under more controlled conditions. Such translational animal models will be also key to studying neurobiological and molecular mechanisms underlying loss of control (Domain
B) and new interventions (Domain C).
To take into account the variance explained by genetic factors which ranges between 40% and 70% for the different SUDs, 16 as well as epigenetic factors, biomaterial will be assessed from all participants at all time points. In an innovative approach, the data from genomeand epigenome-wide analyses will be integrated into the computational models mentioned above.
| RESEARCH DOMAIN B: BEHAVIORAL AND COGNITIVE CONTROL MECHANISMS AND THEIR MOLECULAR/ NEUROBIOLOGICAL CORRELATES UNDERLYING LOSING AND REGAINING CONTROL
The second goal is to identify and to computationally model key mechanisms mediating the effects of such triggers and modifying factors on goal-directed, habitual, and compulsive aspects of behavior in corresponding human studies and animal experiments. In Domain B, F I G U R E 2 We will acquire a highly phenotyped cohort of female and male subjects with substance use disorder (SUD) (N = 900 patients plus 150 age-matched controls) focusing on alcohol use but allowing comorbidity with other drugs of abuse. Subjects with SUD will use apps and handheld devices for Ecological Momentary Assessment (EMA) including accelerometers to measure physical activity. Stress and drug exposure, supportive social encounters, and trajectories of increasing or decreasing drug intake, as well as binging, will regularly be monitored over the observation time of one year (sparse sampling). Multi-modal neuroimaging will be acquired at months 3 and 9. For in-depth assessment of cognitive control, we will use additional apps to assess working memory and other executive functions in real life with respect to drug intake ort. In addition, we will assess stress reactivity profiles and explore their interaction with trajectories of craving and alcohol intake. Besides this sparse data sampling approach, we will use specialized apps for intensive EMA to collect e-Diaries, sensor, and geolocation data in subjects at course transition points, ie, with substantial increases and decreases of alcohol intake (intense sampling). This intensive data sampling will provide detailed information on momentary effects of triggers on subjective craving, mood, impulsivity, physiological responses, and alcohol consumption in real-world settings, identify their neural correlates, and test the predictive value of the identified mechanisms for subsequent course trajectories. Finally, data integration and postprocessing will yield early warning signs and tipping points in drug consumption and will allow us to computational model trajectories of alcohol consumption the impact of triggers and modulating factors on the proposed learning and control mechanisms in subjects with AUD deriving from our longitudinal real-life assessment (such as stress, cue exposure, and physical activity) will be assessed in laboratory experiments and compared with tobacco use disorder (TUD) in order to achieve generalizability of our conclusions. Closely linked human studies and animal experiments will assess key learning and control mechanisms and measure their neurobiological and molecular correlates that contribute to a shift from goal-directed to habitual and ultimately compulsive drug consumption and their potential readjustment when regaining goal-directed control. In particular, we will examine and build compu- working memory and craving regulation and their respective impact on drug intake, and (iv) we will use neurofeedback to modulate key brain areas associated with cue-reactivity and control over drug intake. 17 In a 12-year perspective, we will assess cognitive, emotional, and ing. Domain C will thus increasingly be able to identify the most efficient intervention strategies to strengthen control mechanisms and to alter aberrant learning mechanisms. This will result in specific mechanism-based intervention strategies for alcohol-dependent patients and patients suffering from other addictions.
| Summary and outlook
Here, we suggest a set of approaches in addiction research which can promote understanding the mechanisms underlying losing versus regaining control over drug intake. Specifically, a dimensional approach can help to facilitate long-term assessment of subjects with mild to moderate AUD who do not need to be detoxified. Among these subjects with AUD, technical advances in m-health tools such as EMA, GPS-based geolocation, and mobile sensors allow monitoring of behavior, cognitive-emotional states, stress reactivity, and environmental exposures under real-life conditions. Computational and AIbased models can then be applied to these data in order to identify key computational steps in goal-directed and habitual decision-making and their neurobiological correlates in reward-related learning, stressreactivity, and cognitive control. 
